-

Evercore Board of Directors Authorizes $1.4 Billion Share Repurchase Program

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that its Board of Directors has authorized a share repurchase program of up to the lesser of $1.4 billion or 10 million shares of Evercore Inc. Class A common stock and/or Evercore LP Units.

This authorization reflects Evercore’s continued commitment to its capital return objectives, which include offsetting dilution associated with annual bonus equity and new hire grants through share repurchases and returning excess cash not needed for investment in the business through share repurchases.

The Board’s authorization permits Evercore to make purchases of its Class A common stock and/or Evercore LP Units from time to time in open market transactions, in privately negotiated transactions or otherwise, subject to market and other conditions, up to the aggregate amount authorized by the Board. The Board’s authorization has no expiration date and the timing and the actual amount of shares and/or LP units repurchased will depend on a variety of factors, including our liquidity position, legal requirements, and price, economic and market conditions.

About Evercore
Evercore (NYSE: EVR) is a premier global independent investment banking advisory firm. We are dedicated to helping our clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings, and capital structure. Evercore also assists clients in raising public and private capital and delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. Founded in 1995, the Firm is headquartered in New York and maintains offices and affiliate offices in major financial centers in North America, Europe, South America, the Middle East and Asia. For more information, please visit www.evercore.com.

Contacts

Investors:
Investor Relations
investorrelations@evercore.com

Media:
Dana Gorman
The Abernathy MacGregor Group, for Evercore
+1.212.371.5999

Evercore

NYSE:evr

Release Versions

Contacts

Investors:
Investor Relations
investorrelations@evercore.com

Media:
Dana Gorman
The Abernathy MacGregor Group, for Evercore
+1.212.371.5999

More News From Evercore

David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

NEW YORK--(BUSINESS WIRE)--Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. “We are excited to welcome David to Evercore,” said Naveen Nataraj, co-head of U.S. investment banking. “Biotechnology remains one of the most dynamic sectors in equity capital markets, and David’s experience and deep investor relationships enhance our capabilities as we continue to suppor...

Evercore Wealth Management Promotes Sean Brady to Partner

NEW YORK--(BUSINESS WIRE)--Evercore Wealth Management today announced the promotion of Sean Brady to partner. Mr. Brady is a wealth & fiduciary advisor at Evercore Wealth Management and its affiliate, Evercore Trust Company. “Sean is an experienced and thoughtful advisor,” said Chris Zander, CEO of Evercore Wealth Management and Evercore Trust Company. “He is a strong contributor to our firm, able to manage complex planning challenges while always putting our clients first and working well...

Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

NEW YORK--(BUSINESS WIRE)--Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. “We are pleased to welcome Ben to Evercore,” said Naveen Nataraj, co-head of U.S. investment banking. “His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform.” “We...
Back to Newsroom